Updated: September 02, 2010

Announcement


 
Receive timely journal content right in your inbox.

Email Address:



  
 
Advanced

Provided as a service
to the profession by the
following supporters:



Merck
Lilly Sankyo
Atcor
XOMA

   
 
Aug 23, 2010 
Overcoming suboptimal platelet reactivity inhibition

A new study provides evidence of a benefit in adjusting clopidogrel loading doses in carriers of the CYP 2C19 2* loss-of-function polymorphism.

Bonello L, Armero S, Ait Mokhtar O, Mancini J, Aldebert P, Sau N, et al
Journal of the American College of Cardiology. 2010; 56: epublished ahead of print August 11
 
 
      View complete library of Literature Updates

  
 
      Click here to join VBWG



  
      
    
  
    

 
 
    View complete library of Online Lectures

Jun 24, 2010 
Autologous CD34+ Cell Therapy for Critical Limb Ischemia
Douglas W. Losordo, MD
Northwestern University
Chicago, Illinois
Dec 16, 2009 
Advancing Knowledge and Tackling Important Clinical Questions in Atrial Fibrillation Management
CME highlights of a VBWG Town Hall exploring the new era in atrial fibrillation management
Dec 15, 2009 
Advancing Knowledge and Tackling Important Clinical Questions in Atrial Fibrillation Management
CME newsletter of a VBWG Town Hall exploring the new era in atrial fibrillation management
Dec 15, 2009 
Undiagnosed Type 2 Diabetes and Microalbuminuria
George L. Bakris, MD, FASN, FAHA
The University of Chicago – Pritzker
  School of Medicine
Chicago, Illinois
Dec 14, 2009 
Central BP Measurement: Is clinical practice implementation near?
Data Alert CME
Dec 10, 2009 
Progressive Visual Loss in Type 2 Diabetes
Robert J. Chilton, DO
University of Texas Health Science Center
San Antonio, Texas
Dec 2, 2009 
Undiagnosed Type 2 Diabetes and Long-term CV Risk Reduction
Paresh Dandona, MBBS, Dphil, FRCP,
  FACP, FACC, FACE
University at Buffalo
  The State University of New York
Buffalo, New York
Nov 2, 2009 
Role of Platelet Reactivity in Science and Practice
Jane E. Freedman, MD
Professor of Medicine and Pharmacology
Boston University School of Medicine
Boston, Massachusetts
Aug 25, 2009 
Blood Pressure Control in the Age of Combination Therapy in CV Risk Reduction: What Have We ACCOMPLISHed?
George L. Bakris, MD, FASN, FAHA
The University of Chicago –
Pritzker School of Medicine
Chicago, Illinois
 



Get Flash to see this player.





Physician Tools

About Improving Glycemic Control

Case Study Series
 

VBWG 2nd Quarter Report 2010


1 Downloadable file / 89 slides

Contemporary Management of Cardiometabolic Risk
105 slides and content points

VBWG 1st Quarter Report 2010
VBWG 4th Quarter Report 2009
VBWG 3rd Quarter Report 2009
VBWG 2nd Quarter Report 2009
 

Home | Literature Update | Journal Link | Resources | Meeting Highlights | Members | About VBWG | Web Links
 
Contact us at: info@vbwg.org
 
Privacy Policy
 
© 1999-2010 Medtelligence, LLC